X

Xiamen Amoytop Biotech Co Ltd
SSE:688278

Watchlist Manager
Xiamen Amoytop Biotech Co Ltd
SSE:688278
Watchlist
Price: 71.69 CNY -3.54% Market Closed
Market Cap: 29.2B CNY
Have any thoughts about
Xiamen Amoytop Biotech Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Xiamen Amoytop Biotech Co Ltd stock under the Base Case scenario is 86.96 CNY. Compared to the current market price of 71.69 CNY, Xiamen Amoytop Biotech Co Ltd is Undervalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
86.96 CNY
Undervaluation 18%
Intrinsic Value
Price
X
Worst Case
Base Case
Best Case

Valuation Backtest
Xiamen Amoytop Biotech Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Xiamen Amoytop Biotech Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Xiamen Amoytop Biotech Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Xiamen Amoytop Biotech Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Xiamen Amoytop Biotech Co Ltd

Provide an overview of the primary business activities
of Xiamen Amoytop Biotech Co Ltd.

What unique competitive advantages
does Xiamen Amoytop Biotech Co Ltd hold over its rivals?

What risks and challenges
does Xiamen Amoytop Biotech Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Xiamen Amoytop Biotech Co Ltd.

Provide P/S
for Xiamen Amoytop Biotech Co Ltd.

Provide P/E
for Xiamen Amoytop Biotech Co Ltd.

Provide P/OCF
for Xiamen Amoytop Biotech Co Ltd.

Provide P/FCFE
for Xiamen Amoytop Biotech Co Ltd.

Provide P/B
for Xiamen Amoytop Biotech Co Ltd.

Provide EV/S
for Xiamen Amoytop Biotech Co Ltd.

Provide EV/GP
for Xiamen Amoytop Biotech Co Ltd.

Provide EV/EBITDA
for Xiamen Amoytop Biotech Co Ltd.

Provide EV/EBIT
for Xiamen Amoytop Biotech Co Ltd.

Provide EV/OCF
for Xiamen Amoytop Biotech Co Ltd.

Provide EV/FCFF
for Xiamen Amoytop Biotech Co Ltd.

Provide EV/IC
for Xiamen Amoytop Biotech Co Ltd.

Show me price targets
for Xiamen Amoytop Biotech Co Ltd made by professional analysts.

What are the Revenue projections
for Xiamen Amoytop Biotech Co Ltd?

How accurate were the past Revenue estimates
for Xiamen Amoytop Biotech Co Ltd?

What are the Net Income projections
for Xiamen Amoytop Biotech Co Ltd?

How accurate were the past Net Income estimates
for Xiamen Amoytop Biotech Co Ltd?

What are the EPS projections
for Xiamen Amoytop Biotech Co Ltd?

How accurate were the past EPS estimates
for Xiamen Amoytop Biotech Co Ltd?

What are the EBIT projections
for Xiamen Amoytop Biotech Co Ltd?

How accurate were the past EBIT estimates
for Xiamen Amoytop Biotech Co Ltd?

Compare the revenue forecasts
for Xiamen Amoytop Biotech Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Xiamen Amoytop Biotech Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Xiamen Amoytop Biotech Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Xiamen Amoytop Biotech Co Ltd compared to its peers.

Compare the P/E ratios
of Xiamen Amoytop Biotech Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Xiamen Amoytop Biotech Co Ltd with its peers.

Analyze the financial leverage
of Xiamen Amoytop Biotech Co Ltd compared to its main competitors.

Show all profitability ratios
for Xiamen Amoytop Biotech Co Ltd.

Provide ROE
for Xiamen Amoytop Biotech Co Ltd.

Provide ROA
for Xiamen Amoytop Biotech Co Ltd.

Provide ROIC
for Xiamen Amoytop Biotech Co Ltd.

Provide ROCE
for Xiamen Amoytop Biotech Co Ltd.

Provide Gross Margin
for Xiamen Amoytop Biotech Co Ltd.

Provide Operating Margin
for Xiamen Amoytop Biotech Co Ltd.

Provide Net Margin
for Xiamen Amoytop Biotech Co Ltd.

Provide FCF Margin
for Xiamen Amoytop Biotech Co Ltd.

Show all solvency ratios
for Xiamen Amoytop Biotech Co Ltd.

Provide D/E Ratio
for Xiamen Amoytop Biotech Co Ltd.

Provide D/A Ratio
for Xiamen Amoytop Biotech Co Ltd.

Provide Interest Coverage Ratio
for Xiamen Amoytop Biotech Co Ltd.

Provide Altman Z-Score Ratio
for Xiamen Amoytop Biotech Co Ltd.

Provide Quick Ratio
for Xiamen Amoytop Biotech Co Ltd.

Provide Current Ratio
for Xiamen Amoytop Biotech Co Ltd.

Provide Cash Ratio
for Xiamen Amoytop Biotech Co Ltd.

What is the historical Revenue growth
over the last 5 years for Xiamen Amoytop Biotech Co Ltd?

What is the historical Net Income growth
over the last 5 years for Xiamen Amoytop Biotech Co Ltd?

What is the current Free Cash Flow
of Xiamen Amoytop Biotech Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Xiamen Amoytop Biotech Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Xiamen Amoytop Biotech Co Ltd

Current Assets 1.3B
Cash & Short-Term Investments 670m
Receivables 459.7m
Other Current Assets 210.4m
Non-Current Assets 1B
Long-Term Investments 37.4m
PP&E 541.9m
Intangibles 352.7m
Other Non-Current Assets 84m
Current Liabilities 403.7m
Accounts Payable 40.6m
Accrued Liabilities 243.7m
Other Current Liabilities 119.3m
Non-Current Liabilities 76m
Long-Term Debt 3.8m
Other Non-Current Liabilities 72.3m
Efficiency

Earnings Waterfall
Xiamen Amoytop Biotech Co Ltd

Revenue
2.2B CNY
Cost of Revenue
-152m CNY
Gross Profit
2.1B CNY
Operating Expenses
-1.4B CNY
Operating Income
722m CNY
Other Expenses
-121.9m CNY
Net Income
600.1m CNY

Free Cash Flow Analysis
Xiamen Amoytop Biotech Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Xiamen Amoytop Biotech Co Ltd's profitability score is 78/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROIC
Exceptional 3-Years Revenue Growth
Exceptional ROIC
78/100
Profitability
Score

Xiamen Amoytop Biotech Co Ltd's profitability score is 78/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Xiamen Amoytop Biotech Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
86/100
Solvency
Score

Xiamen Amoytop Biotech Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Xiamen Amoytop Biotech Co Ltd

Wall Street analysts forecast Xiamen Amoytop Biotech Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Xiamen Amoytop Biotech Co Ltd is 73.96 CNY with a low forecast of 50 CNY and a high forecast of 100.3 CNY.

Lowest
Price Target
50 CNY
30% Downside
Average
Price Target
73.96 CNY
3% Upside
Highest
Price Target
100.3 CNY
40% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Xiamen Amoytop Biotech Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Xiamen Amoytop Biotech Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Xiamen Amoytop Biotech Co Ltd

Country

China

Industry

Biotechnology

Market Cap

29.2B CNY

Dividend Yield

0%

Description

Xiamen Amoytop Biotech Co. Ltd. engages in the research and development of genetic engineering technology. The company is headquartered in Xiamen, Fujian and currently employs 1,261 full-time employees. The company went IPO on 2020-01-17. The firm's main research and development direction is immune-related cytokine drugs, focusing on systemic immune solutions based on cytokine drugs, and its products mainly include Peginterferon alfa-2b Injection, rhGM-CSF (Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor for Injection), rHuG-CSF (Recombinant Human Granulocyte-Colony Stimulating Factor for Injection) and Recombinant Human Interleukin-11 for Injection. The firm distributes its products within domestic market and to overseas markets.

Contact

FUJIAN
Xiamen
No.330 Wengjiao Road, Haicang Xinyang Industry Zone
+865926889118
www.amoytop.com

IPO

2020-01-17

Employees

1 261

Officers

Chairman & GM
Mr. Li Sun
Financial Director, Deputy GM, Secretary of the Board, & CFO
Ms. Yiling Yang
Director & Deputy GM
Ms. Liping Lai
Deputy General Manager
Mr. Fanghe Chen
Technical Director of R&D Center
Ms. Shiyuan Wang
Director of Intellectual Property Management
Ms. Ping Zou

See Also

Discover More
What is the Intrinsic Value of one Xiamen Amoytop Biotech Co Ltd stock?

The intrinsic value of one Xiamen Amoytop Biotech Co Ltd stock under the Base Case scenario is 86.96 CNY.

Is Xiamen Amoytop Biotech Co Ltd stock undervalued or overvalued?

Compared to the current market price of 71.69 CNY, Xiamen Amoytop Biotech Co Ltd is Undervalued by 18%.

Back to Top